News Search Results
Dec 19, 2025, 08:43 ET Mercury Bio and Meta-Flux Announce Strategic Collaboration to Advance Large-Molecule Therapeutics for Parkinson's and Alzheimer's Diseases
Mercury Bio, a biotechnology company advancing large-molecule therapeutics for neurodegenerative disease, and
More news about: Mercury Bio Inc. & Meta-Flux
Dec 19, 2025, 08:30 ET Xtalks Life Science Podcast Wraps Up 2025 with Deep Dives into Drug Development, Regulation, Clinical Trials and Innovation, Sets Sights on a Transformative 2026 by Xtalks
Throughout 2025, the podcast featured executives, scientists and industry experts from across pharmaceutical, biotechnology, medical device and healthcare organizations. Episodes explored topics ranging from drug development strategy and clinical trial innovation to regulatory
More news about: Xtalks
Dec 19, 2025, 07:45 ET BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
LINK.About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based
More news about: BioMarin Pharmaceutical Inc.
Dec 19, 2025, 06:59 ET Probiotic Yeast Market worth $16.23 billion by 2030- Exclusive Report by MarketsandMarkets™
a whole has become an efficient and competent producing medium for probiotic yeast, driven largely by cheap fermentation facilities, a skilled biotechnology workforce, and easy access to the main markets, allowing many firms to scale up production to serve both regional and export markets.The
More news about: MarketsandMarkets
Dec 19, 2025, 03:17 ET Aquaporin updates on strategic review and sets mid-and long-term financial targets
Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, hereby updates on its strategic review and provides preliminary 2026 guidance and certain information on its mid- and long-term strategy. Update
More news about: Aquaporin A/S
Dec 19, 2025, 03:16 ET Aquaporin initiates rights issue
Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders
More news about: Aquaporin A/S
Dec 19, 2025, 03:11 ET Aquaporin initiates rights issue
Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders
More news about: Aquaporin A/S
Dec 19, 2025, 02:58 ET Aquaporin updates on strategic review and sets mid-and long-term financial targets
Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, hereby updates on its strategic review and provides preliminary 2026 guidance and certain information on its mid- and long-term strategy. Update
More news about: Aquaporin A/S
Dec 19, 2025, 00:00 ET MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan
Korea, Dec. 19, 2025 /PRNewswire/ -- MEDIPOST Co., Ltd. (KOSDAQ 078160), a fully integrated cell therapy biotechnology company, today announced a multi-year partnership with Japan's Teikoku Seiyaku Co., Ltd. for the commercialization of CARTISTEM®, an
More news about: MEDIPOST
Dec 18, 2025, 20:26 ET Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Calif., Dec. 18, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced the closing of its previously announced
More news about: Kodiak Sciences Inc.
Dec 18, 2025, 16:39 ET AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis
regulations related to environmental protection, health and safety. Cannabis-related companies may also be subject to risks associated with the biotechnology and pharmaceutical industries. These risks include increased government regulation, the use and enforcement of intellectual property rights and
More news about: AdvisorShares
Dec 18, 2025, 09:06 ET ATTENTION NASDAQ: SKYE INVESTORS: Contact Berger Montague About a Skye Bioscience, Inc. Class Action Lawsuit
CLICK HERE.Skye, headquartered in San Diego, is a clinical-stage biotechnology company developing treatments for obesity and metabolic diseases.The complaint asserts that, throughout the Class Period, Defendants failed
More news about: Berger Montague
Dec 18, 2025, 09:00 ET Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance
valuation re-rating as partnership discussions advanceSeasonal year-end portfolio positioning effects"In biotechnology, strategic partnerships and external validation events are often catalysts that prompt investors to reassess both risk and long-term opportunity,"
More news about: Lunai Bioworks Inc.
Dec 18, 2025, 09:00 ET Century Health and Tessel Biosciences Collaborate to Apply AI-Curated Real World Data to Advance Early Drug Development in COPD
Tessel Biosciences, a biotechnology company that combines human organoids and machine learning to model chronic disease, today announced a collaboration through which Tessel will leverage
More news about: Century Health
Dec 18, 2025, 09:00 ET Freda Key C Presents Advanced Recombinant Collagen Delivery Technology at SCC79
product development. SCC79 is one of the most influential global forums in cosmetic chemistry, bringing together leading scientists, formulators, and biotechnology innovators.
More news about: Shandong Freda Biotech Co., Ltd.
Dec 18, 2025, 07:30 ET Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford)
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Dec 18, 2025, 07:26 ET Amity University Lucknow Campus Confers Degrees on 1,730 Graduates at 21st Convocation
programmes and more than 7,000 students currently enrolled. Its specialised research centres are active in emerging fields such as nanotechnology, biotechnology, electronics, agriculture and forensic sciences.Addressing the graduates, Dr. Aseem Chauhan, Chairman, Amity University Lucknow Campus, said
More news about: Amity University
Dec 18, 2025, 07:05 ET REGENXBIO to Present at the 44th Annual J.P. Morgan Healthcare Conference
of the webcast will be available for approximately 30 days following the presentation.ABOUT REGENXBIO Inc. REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Dec 18, 2025, 07:00 ET U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with ENHANZE® for the Treatment of Advanced EGFR-mutated Non-Small Cell Lung Cancer
than one million patient lives through ten commercialized products across over 100 global markets and is licensed to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical, Acumen
More news about: Halozyme Therapeutics, Inc.
Dec 18, 2025, 06:45 ET Marathon Petroleum Corp. Names Maria A. Khoury as Chief Financial Officer
Boards of Directors, I thank John for his many contributions to MPC and MPLX."Since 2021, Khoury has served as Vice President, Group CFO Biotechnology for Danaher, a global science and technology innovator, where she has finance responsibility for Cytiva (formerly GE Healthcare Biopharma) and Pall
More news about: Marathon Petroleum Corporation
Dec 18, 2025, 06:45 ET Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Dec 18, 2025, 04:00 ET Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients
Therapeutics (ASX: AGN) is a Perth-based biotechnology company developing innovative neuroprotective therapies to protect brain cells following stroke, traumatic brain injury, and other neurological
More news about: Brainomix
Dec 18, 2025, 02:00 ET New Data from SkylineDx Demonstrates Merlin CP-GEP Test's Superior Melanoma Risk Stratification
www.merlinmelanomatest.com.About SkylineDxSkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, and inflammatory and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Dec 17, 2025, 22:30 ET TÜV Rheinland Reinforces Global Contamination Control with Clean Room Validation Services
strengthened its commitment to quality, safety and compliance through its enhanced Clean Room Validation Services. As sectors such as pharmaceuticals, biotechnology, healthcare, electronics, aerospace and food production move toward increasingly stringent sterility and contamination-control requirements, precise
More news about: TUV Rheinland India
Dec 17, 2025, 21:31 ET CorestemChemon Advances Toward ALS Stem Cell Commercialization with Regulatory Progress in Korea and NSF-Backed U.S. Expansion
Innovation Engine, a U.S. regional innovation cluster supported by the National Science Foundation (NSF). The company stated that it is the first Korean biotechnology firm to be included in an NSF-backed regenerative medicine ecosystem.The selection was initiated by the Wake Forest Institute for Regenerative
More news about: CorestemChemon Inc.